Fibrinogen Early In Severe Trauma studY (FEISTY): study protocol for a randomised controlled trial
Abstract Background Haemorrhage is a leading cause of death in severe trauma. Fibrinogen plays a critical role in maintaining haemostasis in traumatic haemorrhage. Early fibrinogen replacement is recommended by several international trauma guidelines using either fibrinogen concentrate (FC) or cryop...
Main Authors: | James Winearls, Martin Wullschleger, Elizabeth Wake, Catherine Hurn, Jeremy Furyk, Glenn Ryan, Melita Trout, James Walsham, Anthony Holley, Jeremy Cohen, Megan Shuttleworth, Wayne Dyer, Gerben Keijzers, John F Fraser, Jeffrey Presneill, Don Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-017-1980-x |
Similar Items
-
Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children
by: Gemma Louise Crighton, et al.
Published: (2021-04-01) -
Importance of fibrinogen in dilutional coagulopathy after neurosurgical procedures: A descriptive study
by: Shalini Nair, et al.
Published: (2016-01-01) -
Cryoprecipitate transfusion: current perspectives
by: Wong H, et al.
Published: (2016-09-01) -
Fibers Generated by Plasma Des-AA Fibrin Monomers and Protofibril/Fibrinogen Clusters Bind Platelets: Clinical and Nonclinical Implications
by: Dennis K. Galanakis, et al.
Published: (2021-07-01) -
Early administration of fibrinogen concentrate is associated with improved survival among severe trauma patients: a single-centre propensity score-matched analysis
by: Yuki Itagaki, et al.
Published: (2020-01-01)